265 related articles for article (PubMed ID: 31523978)
1. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
Faber J; Bech A; van Bentum P; Gisolf J; Hassing RJ; de Boer H
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):58-64. PubMed ID: 31523978
[TBL] [Abstract][Full Text] [Related]
2. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
Das S; Bopitya S; Chowdhury AR; Das A; Taha H
Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
[TBL] [Abstract][Full Text] [Related]
3. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
4. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.
Mondy K; Powderly WG; Claxton SA; Yarasheski KH; Royal M; Stoneman JS; Hoffmann ME; Tebas P
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):426-31. PubMed ID: 15764959
[TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre-exposure prophylaxis.
Pornpaisalsakul K; Songtaweesin WN; Tepmongkol S; Wongharn P; Kawichai S; Suponsilchai V; Anugulruengkitt S; Puthanakit T;
J Int AIDS Soc; 2020 Oct; 23(10):e25624. PubMed ID: 33040465
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Low Dose Oral Vitamin D on Bone Mineral Density Changes in HIV Patients: 36 Months Follow Up.
Dhother J; Bopitiya S; Taha H; Das S
Infect Disord Drug Targets; 2020; 20(5):651-658. PubMed ID: 31258093
[TBL] [Abstract][Full Text] [Related]
7. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
8. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
Geller JL; Hu B; Reed S; Mirocha J; Adams JS
Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035
[TBL] [Abstract][Full Text] [Related]
9. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN
J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilities.
Frighi V; Morovat A; Andrews TM; Rana F; Stephenson MT; White SJ; Fower E; Roast J; Goodwin GM
J Intellect Disabil Res; 2019 Apr; 63(4):357-367. PubMed ID: 30569589
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and vitamin D concentration: the challenges in taking care of children and adolescents infected with HIV.
Carmo FB; Terreri MT; Succi RCM; Beltrão SV; Gouvea AFTB; Paulino ERC; Machado DM
Braz J Infect Dis; 2017; 21(3):270-275. PubMed ID: 28399423
[TBL] [Abstract][Full Text] [Related]
12. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
[TBL] [Abstract][Full Text] [Related]
13. [Are bones in HIV-infected patient really fragile?].
Biver E; Ciaffi L; Rizzoli R; Calmy A
Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
[TBL] [Abstract][Full Text] [Related]
14. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
17. [Bone mineral density disminution post Roux-Y bypass surgery].
Papapietro K; Massardo T; Riffo A; Díaz E; Araya AV; Adjemian D; Montesinos G; Castro G
Nutr Hosp; 2013; 28(3):631-6. PubMed ID: 23848081
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.
Overton ET; Chan ES; Brown TT; Tebas P; McComsey GA; Melbourne KM; Napoli A; Hardin WR; Ribaudo HJ; Yin MT
Ann Intern Med; 2015 Jun; 162(12):815-24. PubMed ID: 26075752
[TBL] [Abstract][Full Text] [Related]
19. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
